Hers alternatives: match the product and the care

Decide what you want to retain

If you like digital follow-up but need clearer pricing, start by requesting an itemized Hers quote. If you need a different clinical-care arrangement, compare the actual contact and refill process elsewhere. A switch that preserves only the ingredient name may change formulation, preparation, pharmacy and payment obligations all at once.

Ro: look closely at insurance work and care fees

Ro’s service distinction is insurance coordination, with $149 ongoing monthly care plus medication on the reviewed monthly option. Ask which coverage tasks it performs and what fees remain payable if insurance does not approve treatment. A move from Hers should be justified by the care arrangement and matched complete quote, not Ro’s introductory $39 care price.

Sesame: establish a monthly benchmark

Sesame’s reviewed $99 plan bills every 28 days and is a useful shorter-term baseline when evaluating commitment. The prescription bill is separate. Compare that combination with your Hers quote over the period you expect to enroll, including any initial charges. Longer Sesame commitments have different pricing; the monthly baseline should not be silently replaced with a prepaid average.

Mochi: menu breadth changes the comparison

Mochi lists both approved and compounded pathways. Its $79 advertised membership does not include a confirmed complete medication bill, and introductory membership offers can have conditions tied to medication purchases. Compounded drugs are not FDA-approved. If the proposed route changes, ask the prescriber to explain the clinical decision before treating an apparent price reduction as a like-for-like saving.

Transfer only after responsibilities are clear

Ask the prospective service what records it requires, whether a new evaluation is needed and how the first refill is handled. Get the existing provider’s cancellation and order-processing cutoff in writing. We have not tested patient support response times, so service promises should be verified directly rather than read as measured performance.

Sources and comparison limits

We use public information, have not enrolled as patients and do not measure clinical quality or support speed. Individual eligibility, state access, prescription and current terms must be confirmed directly.

• Hers: official service information · Our review
• Ro: official service information · Our review
• Sesame Care: official service information · Our review
• Mochi Health: official service information · Our review
• FDA: concerns with unapproved GLP-1 drugs ↗

Compounded drugs are not FDA-approved. This comparison is not a treatment recommendation. See our commercial disclosure and comparison method.